Evidence map›Paper›PMID 20813865›Full record

ArticleJournal of the American Society of Nephrology : JASN2010

SPAK-knockout mice manifest Gitelman syndrome and impaired vasoconstriction.

Sung-Sen Yang, Yi-Fen Lo, Chin-Chen Wu, Shu-Wha Lin, Chien-Ju Yeh, Pauling Chu, Huey-Kang Sytwu, Shinichi Uchida, Sei Sasaki, Shih-Hua Lin

Open access · hybridAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 159 papers.

0numbers the graph read from it
0cells of the map it votes in
159citing papers in PubMed
8.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

159 citing papers in PubMed, 277 citations in OpenAlex.

  1. Article
  2. Central Osmolality Sensing for Arginine Vasopressin Release Is Mediated by WNK1-OSR1/SPAK-Kv3.1 Cascade.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2025
    Article
  3. Article
  4. Review
  5. Article
  6. Role of ENaC in gender-associated differences in blood pressure.Iranian journal of basic medical sciences · 2025
    Article
  7. Familial Hyperkalemic Hypertension.Comprehensive Physiology · 2024
    Review
  8. Macrophage SPAK deletion limits a low potassium-induced kidney inflammatory program.American journal of physiology. Renal physiology · 2024
    Article
  9. Article
  10. Role of calcineurin in regulating renal potassium (KActa physiologica (Oxford, England) · 2024
    Review
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. The role of uromodulin in cardiovascular disease: a review.Frontiers in cardiovascular medicine · 2024
    Review
  18. Review
  19. Review
  20. Review

99 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 4 countries.

Sung-Sen YangDivision of Nephrology, Department of Medicine, Tri-Service General Hospital, National Defense Medical Center, Taipei, Taiwan.
Yi-Fen Lo
Chin-Chen Wu
Shu-Wha Lin
Chien-Ju Yeh
Pauling Chu
Huey-Kang Sytwu
Shinichi Uchida
Sei Sasaki
Shih-Hua Lin
Institute of Life Sciences · INTokyo Medical and Dental University · JPCzech Academy of Sciences, Institute of Physiology · CZNational Defense Medical Center · TWNational Taiwan University · TWTri-Service General Hospital · TW

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Polymorphisms in the gene encoding sterile 20/SPS1-related proline/alanine-rich kinase (SPAK) associate with hypertension susceptibility in humans. SPAK interacts with WNK kinases to regulate the Na(+)-K(+)-2Cl(-) and Na(+)-Cl(-) co-transporters [collectively, N(K)CC]. Mutations in WNK1/4 and N(K)CC can cause changes in BP and dyskalemia in humans, but the physiologic role of SPAK in vivo is unknown. We generated and analyzed SPAK-null mice by targeting disruption of exons 9 and 10 of SPAK. Compared with SPAK(+/+) littermates, SPAK(+/-) mice exhibited hypotension without significant electrolyte abnormalities, and SPAK(-/-) mice not only exhibited hypotension but also recapitulated Gitelman syndrome with hypokalemia, hypomagnesemia, and hypocalciuria. In the kidney tissues of SPAK(-/-) mice, the expression of total and phosphorylated (p-)NCC was markedly decreased, but that of p-OSR1, total NKCC2, and p-NKCC2 was significantly increased. We observed a blunted response to thiazide but normal response to furosemide in SPAK(-/-) mice. In aortic tissues, total NKCC1 expression was increased but p-NKCC1 was decreased in SPAK-deficient mice. Both SPAK(+/-) and SPAK(-/-) mice had impaired responses to the selective α(1)-adrenergic agonist phenylephrine and the NKCC1 inhibitor bumetanide, suggesting that impaired aortic contractility may contribute to the hypotension of SPAK-null mice. In summary, SPAK-null mice have defects of NCC in the kidneys and NKCC1 in the blood vessels, leading to hypotension through renal salt wasting and vasodilation. SPAK may be a promising target for antihypertensive therapy.

Indexed as

AnimalsAortaBlood PressureDisease Models, AnimalDiureticsFemaleFurosemideGitelman SyndromeHydrochlorothiazideHypotensionMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicProtein Serine-Threonine KinasesDiureticsFurosemideHydrochlorothiazideOXSR1 protein, mouseProtein Serine-Threonine KinasesSodium Chloride SymportersSodium-Potassium-Chloride SymportersStk39 protein, mouse

Identifiers

PMID20813865
PMCPMC3014002
OpenAlexW2097799706

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.